Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Patel Samir Rashmikant Insider Profile
4 Followers
Patel Samir Rashmikant, Director at CytoDyn, holds ― shares in CytoDyn (Ticker: CYDY), holds 5.33B shares in Akari Therapeutics (Ticker: AKTX). Most recently, Patel Samir Rashmikant ― shares of CytoDyn on ― for an estimated value of ―.
Patel Samir Rashmikant has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Patel Samir Rashmikant holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Patel Samir Rashmikant
Patel Samir Rashmikant's Trading History
CytoDyn
―
Director
―
―
Akari Therapeutics
Dec 03, 2024
Director
Uninformative Buy
―
$5.17B
List of latest transactions for each holding click on a transaction to see Patel Samir Rashmikant's performance on stock
You May Also Like
Patel Samir Rashmikant insider profile FAQ
What is the percentage of profitable transactions made by Patel Samir Rashmikant?
The percentage of profitable transactions made by Patel Samir Rashmikant is ―.
What is the average return per transaction made by Patel Samir Rashmikant?
The average return per transaction made by Patel Samir Rashmikant is ―.
What stocks does Patel Samir Rashmikant hold?
Patel Samir Rashmikant holds: CYDY, AKTX stocks.
What was Patel Samir Rashmikant’s latest transaction?
Patel Samir Rashmikant latest transaction was an Uninformative Buy of ―.
What was Patel Samir Rashmikant's most profitable transaction?
Patel Samir Rashmikant’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Patel Samir Rashmikant's role in CytoDyn?
Patel Samir Rashmikant's role in CytoDyn is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.